生物聚合物支架P4HB在复杂腹壁重建中的初步经验
该回顾性研究比较了可吸收聚合物支架P4HB与猪源脱细胞生物补片在复杂腹壁重建中的效果。P4HB组(n=31)相比猪源补片组(n=42)引流时间更短、并发症更少、疝复发率更低,且每例成本优势约9570美元。结论提示P4HB可能提供更优的临床性能和成本效益。
要点
- P4HB组引流时间10.0天,短于猪源补片组的14.3天。
- P4HB组并发症发生率22.6%,低于猪源补片组的40.5%。
- P4HB组疝复发率6.5%,低于猪源补片组的23.8%。
核心结论
- 初步临床经验显示,可吸收聚合物支架P4HB相比猪源脱细胞生物补片在复杂腹壁重建中可能提供更优的临床性能和成本效益。
研究设计与样本
- 回顾性分析,比较P4HB组(n=31)与连续猪源脱细胞生物补片组(n=42)在复杂腹壁重建中的结果,使用SAS 9.3和Stata 12进行分析。
主要发现
- P4HB组引流时间10.0天 vs 猪源补片组14.3天(P<0.002)。
- P4HB组并发症发生率22.6% vs 猪源补片组40.5%(P<0.046)。
- P4HB组疝复发率6.5% vs 猪源补片组23.8%(P<0.049)。
- 多因素分析显示猪源补片与感染(OR 2.82)、并发症(OR 4.03)和疝复发(OR 5.18)相关。
- 成本分析显示P4HB每例在初始住院和出院后90天全局期共节省9570.07美元。
关键数值与推荐
- P4HB组引流时间10.0天,猪源补片组14.3天(P<0.002)。
- P4HB组并发症22.6%,猪源补片组40.5%(P<0.046)。
- P4HB组疝复发6.5%,猪源补片组23.8%(P<0.049)。
- 感染多因素分析:猪源补片OR 2.82,住院时间OR 1.11。
- 疝复发多因素分析:猪源补片OR 5.18,饮酒者OR 3.62,非裔美国人OR 0.24。
临床怎么用
- 在复杂腹壁重建中,P4HB可作为猪源脱细胞生物补片的替代选择,可能减少引流时间、并发症和疝复发。
- P4HB可能降低初始住院及出院后90天内的总体成本。
局限性
- 回顾性研究设计,样本量有限(P4HB组31例,猪源补片组42例)。
- 单中心初步经验,结果需更大规模前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the use of the new absorbable polymer scaffold poly-4-hydroxybutyrate (P4HB) in complex abdominal wall reconstruction. BACKGROUND: Complex abdominal wall reconstruction has witnessed tremendous success in the last decade after the introduction of cadaveric biologic scaffolds. However, the use of cadaveric biologic mesh has been expensive and plagued by complications such as seroma, infection, and recurrent hernia. Despite widespread application of cadaveric biologic mesh, little data exist on the superiority of these materials in the setting of high-risk wounds in patients. P4HB, an absorbable polymer scaffold, may present a new alternative to these cadaveric biologic grafts. METHODS: A retrospective analysis of our initial experience with the absorbable polymer scaffold P4HB compared with a consecutive contiguous group treated with porcine cadaveric mesh for complex abdominal wall reconstructions. Our analysis was performed using SAS 9.3 and Stata 12. RESULTS: The P4HB group (n = 31) experienced shorter drain time (10.0 vs 14.3 d; P < 0.002), fewer complications (22.6% vs 40.5%; P < 0.046), and reherniation (6.5% vs 23.8%; P < 0.049) than the porcine cadaveric mesh group (n = 42). Multivariate analysis for infection identified: porcine cadaveric mesh odds ratio 2.82, length of stay odds ratio 1.11; complications: drinker odds ratio 6.52, porcine cadaveric mesh odds ratio 4.03, African American odds ratio 3.08, length of stay odds ratio 1.11; and hernia recurrence: porcine cadaveric mesh odds ratio 5.18, drinker odds ratio 3.62, African American odds ratio 0.24. Cost analysis identified that P4HB had a $7328.91 financial advantage in initial hospitalization and $2241.17 in the 90-day postdischarge global period resulting in $9570.07 per case advantage over porcine cadaveric mesh. CONCLUSIONS: In our early clinical experience with the absorbable polymer matrix scaffold P4HB, it seemed to provide superior clinical performance and value-based benefit compared with porcine cadaveric biologic mesh.
引用
- Buell JF, Sigmon D, Ducoin C, et al. Initial Experience With Biologic Polymer Scaffold (Poly-4-hydroxybuturate) in Complex Abdominal Wall Reconstruction. Ann Surg. 2017. PMID: 28594679. doi:10.1097/SLA.0000000000001916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。